Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy - Bone Marrow Transplantation
- ️Lange, W
- ️Tue Apr 17 2001
Dexter TM, Allen TD, Lagtha LG . Conditions controlling the proliferation of hematopoietic stem cells in vitro J Cell Physiol 1977 91: 335–344
Gartner S, Kaplan MS . Long-term culture of human bone marrow cells Proc Natl Acad Sci USA 1980 74: 4656–4660
Muench MO, Firpo MT, Moore MAS . Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential Blood 1993 81: 3463–3473
Holyoake L, Alcorn MJ, Richmond L et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens Bone Marrow Transplant 1997 19: 1095–1101
Goltry KL, Koller MR, Maher R et al. Clinical-scale expansion of human umbilical cord blood cells in an automated perfused culture system Bone Marrow Transplant 1998 21: 653–663
Stiff P, Chen B, Franklin W et al. Autologous transplantation of ex vivo expanded bone marrow grown from small aliquots after high-dose chemotherapy for breast cancer Blood 2000 95: 2169–2174
Cashman JD, Lapidot T, Wang J et al. Kinetic evidence of the regeneration of multi-lineage hematopoiesis from primitive cells in normal human bone marrow transplanted immunodeficient mice Blood 1997 89: 4307–4316
Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood Blood 1997 89: 2644–2653
Piacibello W, Sanavio F, Severino A et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells Blood 1999 93: 3736–3749
Engelhardt M, Kumar R, Albanell J et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells Blood 1997 90: 182–193
Moore MAS . Stem cell proliferation: ex vivo and in vivo observations Stem Cells 1997 15: (Suppl. 1) 239–251
Petzer AL, Zandstra PW, Piret JM, Eaves CJ . Differential cytokine effects on primitive (CD34+/CD38−) human hematopoietic cells: novel responses to Flt-3 ligand and thrombopoetin J Exp Med 1996 183: 2551–2558
Koller MR, Palsson MA, Manchel I, Palsson BO . LTCIC expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects Blood 1995 86: 1784–1793
Koller MR, Bradley MS, Palsson BO . Growth factor consumption and production in perfusion cultures of human bone marrow correlate with specific cell production Exp Hematol 1995 23: 1275–1283
Palsson BO, Paek SH, Schwartz RM et al. Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system Biotechnology 1993 11: 368–373
Koller MR, Emerson SG, Palsson BO . Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures Blood 1993 82: 378–384
Silver SM, Adams PT, Hutchinson RJ et al. Phase I evaluation of ex vivo expanded hematopoietic cells produced by perfusion culture in autologous bone marrow transplantation (ABMT) Blood 1993 82: (Suppl) 297a
Lundell BI, Tyer C, DeSombre K et al. Ex vivo perfusion culture expansion of tumor positive bone marrow from breast cancer patients results in passive purging during the culture period Bone Marrow Transplant 1998 22: 153–159
Stiff P, Parthasarathy M, Chen B et al. A single apheresis combined with ex vivo expanded bone marrow cells from a small starting aliquot leads to rapid hematopoietic engraftment following autotransplantation Blood 1998 92: (Suppl. 1) 132
Engelhardt M, Bertz H, Afting M et al. High-versus standard-dose filgrastim significantly improves mobilization of allogeneic blood progenitors and facilitates CD34+ immunoselection J Clin Oncol 1999 17: 2160–2173
Sutherland HJ, Lansdorp PM, Henkelman DJ et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive stromal layers Proc Natl Acad Sci USA 1990 87: 3584–3588
Vogel W, Behringer D, Scheding S et al. Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells Blood 1996 88: 2707–2713
Spyridonidis A, Bernhardt W, Behringer D et al. Proliferation and survival of mammary carcinoma cells are influenced by culture conditions used for ex vivo expansion of CD34+ blood progenitor cells Blood 1999 93: 746–755
Ayash L, Elias A, Ibrahim J et al. High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma J Clin Oncol 1998 16: 1000–1007
Holland HK, Dix SP, Geller RB et al. Minimal toxicity and mortality in high risk breast cancer patients receiving high dose cyclophosphamide, thiotepa and carboplatin plus autologous marrow/stem cell transplantation and comprehensive supportive care J Clin Oncol 1996 14: 1156–1164
Williams SF, Lee WJ, Bender JG et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer Blood 1996 57: 1687–1691
Reiffers J, Calliot C, Dozey B et al. Infusion of expanded CD34+ selected cells can abrogate post myeloablative chemotherapy neutropenia in patients with hematologic malignancies Blood 1998 92: (Suppl. 1) 126a
Schmitz N, Linch DC, Dreger P et al. Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients Lancet 1996 347: 353–357
Glaspy JA, Shpall EJ, LeMaistre CF et al. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients Blood 1997 90: 2939–2951
Breems DA, Blokland EA, Siebel KE et al. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells Blood 1998 91: 111–117
Castro-Malaspina H, Gay RE, Resnick G et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny Blood 1980 56: 289–301
Anklesaria P, Kase K, Glowacki J et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation Proc Natl Acad Sci USA 1987 84: 7681–7685
Engelhardt M, Ozkaynak MF, Drullinsky P et al. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy Leukemia 1998 12: 13–24
Engelhardt M, Mackenzie K, Drullinsky P et al. Telomerase activity and telomere length in CD34+ cells from acute and chronic leukemias, pre-and post-ex vivo expansion Cancer Res 2000 60: 610–617
delCanizo MC, Lopez N, Vazquez I et al. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery Hematologica 1999 84: 511–516
Carlo-Stella C, Tabilio A, Regazzi E et al. Effect of chemotherapy for acute myeloid leukemia on hematopoietic and fibroblast marrow progenitors Bone Marrow Transplant 1997 20: 465–471
Engelhardt M, Lange W, Henschler R et al. Effect of prolonged myelosuppressive chemotherapy treatment on apheresis results and telomere length Blood 1997 929: (Suppl) 211a
Soligo DA, Lambertenghi-Deliliers G, Servida F et al. Hematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients Bone Marrow Transplant 1998 21: 15–22
Galotto M, Berisso G, Delfino L et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients Exp Hematol 1999 27: 1460–1466
Engelhardt M, Schmidt G, Lindemann A, Mertelsmann R . Telomere length analysis to monitor potential proliferative defects in hematopoietic progenitors after autologous peripheral blood stem cell transplantation (PBSCT) Blood 1999 94: (Suppl) 351a
Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy J Clin Oncol 2000 18: 307–316
Mandalam RK, Douville J, Stiff PJ et al. An alternative stem cell transplant source for poor mobilizers: ex vivo expanded bone marrow cells Cytotherapy 1999 1: (Suppl) 243
Notaro R, Cimmino A, Tabarini D et al. In vivo telomere dynamics of human hematopoietic stem cells Proc Natl Acad Sci USA 1997 94: 13782–13785
Wynn RF, Cross MA, Hatton C et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants Lancet 1998 351: 178–181